Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Temporarily not available × OTHER × pembrolizumab × Clear all

Status

Completed 277 Recruiting 273 Active not recruiting 194 Terminated 121 Unknown 93 Withdrawn 77 Not yet recruiting 57 Suspended 6 Temporarily not available 1 No longer available 1 Enrolling by invitation 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Conditions

KRAS G12V Mutant Advanced Epithelial Cancers 1

Interventions

pembrolizumab 1 Insulin Infusion Systems 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05389514 2025-11-20

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Providence Health & Services

Temporarily not available

KRAS G12V Mutant Advanced Epithelial Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡